FTC official: policy steady even as drug prices spike
While sharp rises in generic and branded drug prices in recent years have led to increased attention from Congress and consumers, a Federal Trade Commission lawyer said the agency has kept policy steady.
Subscribe to Global Competition Review
Subscribe and start reading now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10